NEW YORK (GenomeWeb News) – The US House of Representatives and the Senate have passed the Pandemic All Hazards Preparedness Reauthorization Act of 2013, which will provide several billion dollars for development and stockpiling of medical countermeasures (MCMs) for chemical, biological, radiological, and nuclear (CBRN) attacks.

The bill cleared both the House and Senate with overwhelming support over the past few days and has now been submitted to the White House.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The New York Times' George Johnson muses on cancer's roots in multicellularity.

The San Diego Union Tribune wonders whether Medicare is ready for personalized medicine.

Jun Wang, the chief executive of BGI, has stepped down.

In PNAS this week: human T cell editing with CRISPR, retrotransposons acting as insulators, and more.